Skip to main content
. 2016 Jul 13;18:163. doi: 10.1186/s13075-016-1069-z

Table 1.

Diagnostic and prognostic criteria for inclusion

Biomarker function Description Biomarkers identified (n) Number of studies in which biomarkers were identified (n)
Diagnostic D1: SJIA versus other non-arthritis conditions or HC 36 48
D2: SJIA versus other JIA subtypes 25 25
Prognostic P1: for flare (or relapse) 14 16
P2: for increased disease activity and/or the discrimination of active and inactive disease 15 21
P3: for MAS or discriminating MAS from SJIA flare 7 12